In addition, aberrant activation of Tal1, another bHLH inhibitor of E proteins, is the most common cause of human pediatric T cell acute lymphoblastic leukemia (T-ALL) [22], [43]. This evidence concerns the gene TAL1 and T-cell acute lymphoblastic leukemia.